Literature DB >> 31530688

Diabetic ketoacidosis: update on management.

Kate Evans1.   

Abstract

Diabetic ketoacidosis (DKA) is not a rare presentation to hospital, despite being an entirely preventable condition. A concerning number of people also develop DKA while already in hospital. Management of DKA has changed in the last decade, and national guidelines introduced, to help standardise care, spread best practice, and reduce mortality and morbidity.
© 2019 Royal College of Physicians.

Entities:  

Keywords:  diabetic ketoacidosis; type 1 diabetes

Year:  2019        PMID： 31530688      PMCID： PMC6771342          DOI： 10.7861/clinmed.2019-0284

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


  3 in total

1.  Declining death rates from hyperglycemic crisis among adults with diabetes, U.S., 1985-2002.

Authors:  Jing Wang; Desmond E Williams; K M Venkat Narayan; Linda S Geiss
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

Review 2.  Sodium-glucose co-transporter-2 inhibitors and diabetic ketoacidosis: An updated review of the literature.

Authors:  Benedetta Maria Bonora; Angelo Avogaro; Gian Paolo Fadini
Journal:  Diabetes Obes Metab       Date:  2017-07-06       Impact factor: 6.577

3.  Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.

Authors:  Shlomit Shalitin; Sharon Fisher; Michal Yackbovitch-Gavan; Liat de Vries; Liora Lazar; Yael Lebenthal; Moshe Phillip
Journal:  Pediatr Diabetes       Date:  2017-06-01       Impact factor: 4.866
  3 in total
  8 in total

1.  Diabetic ketoacidosis - our local experience.

Authors:  Chin Voon Tong
Journal:  Clin Med (Lond)       Date:  2019-11       Impact factor: 2.659

2.  Hospitalizations for ketoacidosis in type 1 diabetes mellitus, 2008 to 2018.

Authors:  Asim Kichloo; Zain El-Amir; Farah Wani; Hafeez Shaka
Journal:  Proc (Bayl Univ Med Cent)       Date:  2021-10-01

3.  The Impact of Cirrhosis on Outcomes of Patients Admitted With Diabetic Ketoacidosis: A Nationwide Study.

Authors:  Mahmoud M Mansour; Adham E Obeidat; Mohammad Darweesh; Ratib Mahfouz; Scott Kuwada; Nikolaos T Pyrsopoulos
Journal:  Cureus       Date:  2022-06-12

Review 4.  Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review.

Authors:  Maria Stelmachowska-Banaś; Izabella Czajka-Oraniec
Journal:  Endocr Connect       Date:  2020-10       Impact factor: 3.335

5.  Evaluation of Outcomes Following Hospital-Wide Implementation of a Subcutaneous Insulin Protocol for Diabetic Ketoacidosis.

Authors:  Priya Rao; Sheng-Fang Jiang; Patricia Kipnis; Divyesh M Patel; Svetlana Katsnelson; Samineh Madani; Vincent X Liu
Journal:  JAMA Netw Open       Date:  2022-04-01

Review 6.  Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently.

Authors:  Marc Evans; Angharad R Morgan; Stephen C Bain; Sarah Davies; Umesh Dashora; Smeeta Sinha; Samuel Seidu; Dipesh C Patel; Hannah Beba; W David Strain
Journal:  Diabetes Ther       Date:  2022-03-29       Impact factor: 3.595

7.  Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597 children with diabetes.

Authors:  Anas Elgenidy; Ahmed K Awad; Khaled Saad; Mostafa Atef; Hatem Helmy El-Leithy; Ahmed A Obiedallah; Emad M Hammad; Faisal-Alkhateeb Ahmad; Ahmad M Ali; Hamad Ghaleb Dailah; Amira Elhoufey; Samaher Fathy Taha
Journal:  Pediatr Res       Date:  2022-08-11       Impact factor: 3.953

8.  The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: a Literature Review.

Authors:  Mariana Cornelia Tilinca; Maximilian Cosma Gliga; Andreea Varga
Journal:  J Crit Care Med (Targu Mures)       Date:  2021-11-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.